Note: There is no requirement to allocate CERT-year taxable income between pre--and post-CERT dates; any CERILs generated in a subsequent LLY
may be carried back to the CERT year in full, regardless of any taxable income generated before the CERT.
The board of directors of Eli Lilly and Company (NYSE: LLY
), a pharmaceutical products company, on Monday declared a dividend for the second quarter of 2012 of USD0.49 a share on outstanding common stock.
Tickers featured: CHRW, CL, DIS, IBM, JAVA, LLY
, MFC, Mon, ORCL, ROK, SCHW, SGP, SYK, UNH.
DVLA's top 10 highest value classic collection numbers 1 K1 NGS Sold Dec '93 for pounds 231,000 2 1 A Sold Dec '89 for pounds 200,000 3 S1 NGH Sold Oct '98 for pounds 108,000 4 1 RR Sold Dec '94 for pounds 106,000 5 1 S Sold Dec '90 for pounds 100,000 6 G1 LLY
Sold Mar '90 for pounds 87,500 7 1 MK Sold Oct '02 for pounds 83,500 8 P1 LOT Sold Sep '96 for pounds 82,500 9 1 DM Sold Dec '94 for pounds 82,000 10 COL 1N Sold Jun '99 for pounds 76,500
As previously reported, Eli Lilly (LLY
) and Incyte (INCY) confirmed earlier that the U.S.
Tickers featured: ACV, BAC, IDXX, KO, LLY
, MRK, MSFT.
Piper Jaffray analyst Tyler Van Buren noted that the TNF step-through for Incyte (INCY) and Eli Lilly's (LLY
) Olumiant potentially decreases the overall market opportunity, but he believes Olumiant will get some share of TNF failure patients given that Lilly announced it is pricing the drug "aggressively" at a potential 60% price discount to AbbVie's (ABBV) Humira.
The board of directors of pharmaceutical products company Eli Lilly and Company (NYSE: LLY
) on Monday declared a dividend for the first quarter of 2012 of USD0.49 a share, on outstanding common stock.
Tickers featured: AFFX, ALKS, AMGN, AMLN, ARNA, CVTX, DNA, FVRL, GILD, HGSI, ICOS, IMCL, JNJ, LLY
, NBIX, NKTR, NTMD, NVS, OSIP, PDLI, PFE, SEPR, SRA.
Given Zoetis' (ZTS) success as a company and a stock, and Eli Lilly's (LLY
) ongoing review of strategic options for its Elanco Animal Health business, Gilbert conducted a preliminary separation analysis of Merck's animal health unit.
Tickers featured: ABT, AIG, AMGN, BA, CEG, CVX, D, DNA, DUK, EMR, EXC, FPL, GD, GE, GSK, HD, HON, IBM, JNJ, KFT, LLY
, MO, MRO, PEG, PFE, SO, UTX, WYE.
Pfenex (PFNX) and China NT Pharma announced an agreement under which Pfenex granted NT Pharma non-exclusive development and exclusive commercialization rights to PF708, a teriparatide therapeutic equivalent candidate to Eli Lilly's (LLY
) Forteo, in Mainland China, Hong Kong, Singapore, Malaysia and Thailand.